Discovery of a CK2α′-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound LibraryACS CHEMICAL NEUROSCIENCEIF3.92024-06-221PRE
Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's DiseaseBIOMEDICINESIF3.92022-08-159OAAI
CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington's disease (vol 10, 83, 2022)ACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72022-06-220OA
CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's diseaseACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72022-06-0315OAAI